Human renal cell carcinoma antigen-specific CTLs: Antigen-driven selection and long-term persistence in vivo

Cancer Research

Volumn 58, Issue 14, 1998, Pages 3078-3086

  Jantzer, Petra ^a   Schendel, Dolores J ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN;

ANTIGEN SPECIFICITY; ARTICLE; CANCER REGRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0032527921     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Rammensee, H-G., Falk, K., and Roetzschke, O. Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol., 11: 213-244, 1993.
2. Davis, M. M., and Bjorkman, P. J. T-cell antigen receptor genes and T-cell recognition. Nature (Lond.), 334: 395-402, 1988.
3. Engel, I., and Hedrick, S. M. Site-directed mutations in the VDJ junctional region of a T cell receptor βchain cause changes in antigenic peptide recognition. Cell, 54: 473-484, 1988.
4. Jorgensen, J. L., Esser, U., De St. Groth, B. F., Reay, P. A., and Davis, M. M. Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature (Lond.), 355: 224-230, 1992.
5. Garcia, K. C., Degano, M., Stanfield, R. L., Brunmark, A., Jackson, M. R., Peterson, P. A., Teyton, L., and Wilson, I. A. An αβ T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science (Washington DC), 274: 209-219, 1996.
6. Garboczi, D. N., Ghosh, P., Utz, U., Fang, Q. R., Biddison, W. E., and Wiley, D. C. Structure of the complex between human T cell receptor, viral peptide and HLA-A2. Nature (Lond.), 384: 134-141, 1996.
7. Slingluff, C. L., Jr., Hunt, D. F., and Engelhard, V. H. Direct analysis of tumor-associated peptide antigens. Curr. Opin. Immunol., 6: 733-740, 1994.
8. Van den Eynde, B., and Brichard, V. G. New tumor antigens recognized by T cells. Curr. Opin. Immunol., 7: 674-681, 1995.
9. Sensi, M., and Parmiani, G. Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses. Immunol. Today, 16: 588-595, 1995.
10. McHeyzer-Williams, M. G., and Davis, M. M. Antigen-specific development of primary and memory T cells in vivo. Science (Washington DC), 268: 106-111, 1995.
11. Maryanski, J. L., Jongeneel, C. V., Bucher, P., Casanova, J. L., and Walker, P. R. Single-cell PCR analysis of TCR repertoires selected by antigen in vivo: a high magnitude CD8 response is comprised of very few clones. Immunity, 4: 47-55, 1996.
12. Schendel, D. J., Oberneder, R., Falk, C. S., Jantzer, P., Kressenstein, S., Maget, B., Hofstetter, A., Riethmueller, G., and Noessner, E. Cellular and molecular analyses of MHC-restricted and non-MHC-restricted effector cells recognizing renal cell carcinomas: problems and perspectives for immunotherapy. J. Mol. Med., 75: 400-413, 1997.
13. Boon, T., Cerottini, J-C., Van den Eynde, B., Van der Bruggen, P., and Van Pel, A. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol., 12: 337-365, 1994.
14. Brouwenstijn, N., Gaugler, B., Kruese, K. M., Van der Spek, C. W., Mulder, A., Osanto, S., Van den Eynde, B. J., and Schrier, P. I. Renal cell carcinoma-specific lysis by cytotoxic T-lymphocyte clones isolated from peripheral blood lymphocytes and tumor-infiltrating lymphocytes. Int. J. Cancer, 68: 177-182, 1996.
15. Gaugler, B., Brouwenstijn, N., Van Tomme, V., Szikora, J., Van der Spek, C. W., Patard, J., Boon, T., Schrier, P., and Van den Eynde, B. J. A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma. Immunogenetics, 44: 323-330, 1996.
16. Braendle, D., Brasseur, F., Weynants, P., Boon, T., and Van den Eynde, B. J. A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma. J. Exp. Med., 183: 2501-2508, 1996.
17. Schendel, D. J., Gansbacher, B., Oberneder, R., Kriegmair, M., Hofstetter, A., Riethmueller, G., and Segurado, O. G. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines. J. Immunol., 151: 4209-4220, 1993.
18. Pitz, S., Moll, R., Stoerkel, S., and Thoenes, W. Expression of intermediate filament proteins in subtypes of renal cell carcinomas and in renal oncocytomas. Distinction of two classes of renal cell tumors. Lab. Investig., 56: 642-653, 1987.
19. Oosterwijk, E., Ruiter, D. J., Hoedemaeker, P. J., Pauwels, E. K. J., Jonas, U., Zwartenduk, J., and Warnaar, S. O. Monoclonal antibody G 250 recognizes a determinant present in renal cell carcinoma and absent from normal kidney. Int. J. Cancer, 38: 489-494, 1986.
20. Steinle, A., Reinhardt, C., Jantzer, P., and Schendel, D. J. In vivo expansion of HLA-B35 alloreactive T cells sharing homologous T cell receptors: evidence for maintenance of an oligoclonally dominated allospecificity by persistent stimulation with an autologous MHC/peptide complex. J. Exp. Med., 181: 503-513, 1995.
21. Broeren, C. P. M., Verjans, G. M. G. M., Van Eden, W., Kusters, J. G., Lenstra, J. A., and Logtenberg, T. Conserved nucleotide sequences at the 5′ end of T cell receptor variable genes facilitate polymerase chain reaction amplification. Eur. J. Immunol., 21: 569-575, 1991.
22. Choi, Y., Kotzin, B., Herron, L., Callahan, J., Marrack, P., and Kappler, J. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc. Natl. Acad. Sci. USA, 86: 8941-8945, 1989.
23. Bernhard, H., Jaeger, E., Maeurer, M. J., Zum Bueschenfelde, K. H. M., and Knuth, A. Tumor associated antigens in human renal cell carcinoma: MHC-restricted recognition by cytotoxic T lymphocytes. Tissue Antigens, 48: 22-31, 1996.
24. Arden, B., Clark, S. P., Kabelitz, D., and Mak, T. W. Human T cell receptor variable gene segment families. Immunogenetics, 42: 455-500, 1995.
25. Koop, B. F., Rowen, L., Wang, K., Kuo, C. L., Seto, D., Lenstra, J. A., Howard, S., Shan, W., Deshpande, P., and Hood, L. E. The human T-cell receptor TCRαβ/TCRγδ (Cα/Cδ) region: organization, sequence, and evolution of 97.6 kb of DNS. Genomics, 19: 478-493, 1994.
26. Toyonaga, B., Yoshikai, Y., Vadaz, V., Chin, B., and Mak, T. W. Organization and sequences of the diversity, joining and constant region genes of the T cell receptor β chain. Proc. Natl. Acad. Sci. USA, 82: 8624-8628, 1985.
27. Quiros Roldan, E., Sottini, A., Bettinardi, A., Albertini, A., Imberti, L., and Primi, D. Different TCRBV genes generate biased patterns of V-D-J diversity in human T cells. Immunogenetics, 41: 91-100, 1995.
28. Moss, P. A. H., and Bell, J. I. Sequence analysis of the human αβ T cell receptor CDR3 region. Immunogenetics, 42: 10-18, 1995.
29. Moss, P. A. H., and Bell, J. I. The human T cell receptor repertoire. In: J. I. Bell, M. J. Owen, and E. Simpson (eds.), T Cell Receptors, pp. 46-69. Oxford, New York, Tokyo: Oxford University Press, 1995.
30. Casanova, J-L., and Maryanski, J. L. Antigen-selected T cell receptor diversity and self-nonself homology. Immunol. Today, 14: 391-394, 1993.
31. Shilyansky, J., Nishimura, M. I., Yannelli, J. R., Kawakami, Y., Jacknin, L. S., Charmley, P., and Rosenberg, S. A. T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines. Proc. Natl. Acad. Sci. USA, 91: 2829-2833, 1994.
32. + T cells with a predominant Vβ usage during the primary immune response to HIV. Nature (Lond.), 370: 463-467, 1994.
33. Kalams, S. A., Johnson, R. P., Trocha, A. K., Dynan, M. J., Ngo, H. S., D'Aquila, R. T., Kurnick, J. T., and Walker, B. D. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med., 179: 1261-1271, 1994.
34. Mackensen, A., Carcelain, G., Viel, S., Raynal, M-C., Michalaki, H., Triebel, F., Bosq, J., and Hercend, T. Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J. Clin. Investig., 93: 1397-1402, 1994.
35. Puisieux, I., Even, J., Pannetier, C., Jotereau, F., Favrot, M., and Kourilsky, P. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J. Immunol., 153: 2807-2818, 1994.
36. Gaudin, C., Dietrich, P-Y., Robache, S., Guillard, M., Escudier, B., Lacombe, M-J. T., Kumar, A., Triebel, F., and Caignard, A. In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma. Cancer Res., 55: 685-690, 1995.
37. Puisieux, I., Bain, I., Merrouche, Y., Malacher, P., Kourilsky, P., Even, J., and Favrot, M. Restriction of the T-cell repertoire in tumor-infiltrating lymphocytes from nine patients with renal-cell carcinoma. Relevance of the CDR3 length analysis for the identification of in situ clonal T-cell expansions. Int. J. Cancer, 66: 201-208, 1996.
38. Angevin, E., Kremer, F., Gaudin, C., Hercend, T., and Triebel, F. Analysis of T cell immune response in renal cell carcinoma: polarization to type 1-like differentiation pattern, clonal T-cell expansion and tumor-specific cytotoxicity. Int. J. Cancer, 72: 431-440, 1997.
39. Sensi, M., Salvi, S., Castelli, C., Maccalli, C., Mazzocchi, A., Mortarini, R., Nicolini, G., Herlyn, M., Parmiani, G., and Anichini, A. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR β chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone. J. Exp. Med., 178: 1231-1246, 1993.
40. Caignard, A., Guillard, M., Gaudin, C., Escudier, B., Triebel, F., and Dietrich, P. Y. In situ demonstration of renal cell carcinoma-specific T-cell clones. Int. J. Cancer, 66: 564-570, 1996.
41. Maryanski, J. L., Casanova, J. L., Falk, K., Gournier, H., Jaulin, C., Kourilsky, P., Lemonnier, F. A., Luthy, R., Rammensee, H. G., Rotzschke, O., Servis, C., and Lopez, J. A. The diversity of antigen-specific TCR repertoires reflects the relative complexity of epitopes recognized. Hum. Immunol., 54: 117-128, 1997.
42. Restifo, N. P., Marincola, F. M., Kawakami, Y., Taubenberger, J., Yannelli, J. R., and Rosenberg, S. A. Loss of functional β2-microglobulin in metastatic melanomas from five patients receiving immunotherapy. J. Natl. Cancer Inst., 88: 100-108, 1996.
43. Jaeger, E., Ringhoffer, M., Altmannsberger, M., Arand, M., Karbach, J., Jager, D., Oesch, F., and Knuth, A. Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma. Int. J. Cancer, 71: 142-147, 1997.
44. Stoerkel, S., Keymer, R., Steinbach, F., and Thoenes, W. Reaction patterns of tumor-infiltrating lymphocytes in different renal cell carcinomas and oncocytomas. Prog. Clin. Biol. Res., 378: 217-223, 1992.
45. + subset in normal human subjects. J. Immunol., 151: 5762-5769, 1993.
46. + T cells by B7-transfected melanoma cells. Science (Washington DC), 259: 368-370, 1993.
47. Pardoll, D. M. Paracrine cytokine adjuvants in cancer immunotherapy. Annu. Rev. Immunol., 13: 399-415, 1995.